Biocenter Oulu launched a BioParts ERDF project
University of Oulu Biocenter Oulu’s research infrastructure services related to biomolecules: structural biology, protein analysis and biocomputing, have launched a BioParts project funded by the European Regional Development Fund. The project aims to create a multidisciplinary research and development platform for the studies of biological nanoparticles by widening the instruments and technologies available through Biocenter Oulu.
Biocenter Oulu maintains and develops life sciences and biomedical research infrastructure services and offers them on an open-access principle to support research and development projects of academic and other customers. Biomolecular services focus especially on supporting research of proteins, but also other biological particles, and related product development.
Nanoparticles are a diverse group of very small particles, ranging in size from nanometers to micrometers, and consisting of one or more different molecules. The specific physical and chemical characteristics of nanoparticles, such as large surface area relative to volume, optical and electrical properties, and the ability to act as carriers or catalysts, make them valuable in many active research fields. Nanoparticles are applied in various fields, including pharmaceutical transportation, material development, and environmental and climate analytics. The importance of nanoparticles as research subjects in life sciences and biomedicine has increased with the development of new research methods. The investment project will provide new enabling technologies for interdisciplinary fields of bionanoparticle research and development.
The BioParts project focuses on enhancing services for characterizing the structural properties, behavior, and dynamics of biological nanoparticles, including macromolecular complexes and vesicles, using state-of-the-art methods in mass spectrometry, 3D structural analysis, and in silico modeling and simulation. The R&D services provided will have applications in diagnostics, separation methods, biosensors, and nanoscale structural studies, helping material design and the atmosphere and environment research, and leading to the development of new therapeutics. Bionanoparticles can be used to develop more accurate diagnostic methods and more effective treatments, for example, for cancer, inflammation, or neurodegenerative diseases that are actively studied in Oulu University.
The investments will be used to expand Biocenter Oulu’s services and support the research of nanoparticles and the productization of research results. Machine learning and AI can be used today to increase the effectiveness of research services. The project also looks into the development of a computational environment utilising machine learning for nanoparticle data analytics and workflows, and to develop simulations and modeling.
The BioParts project started in May 2025 and will continue until the end of 2027. To initiate communication with the local community, we will participate in the University Business Forum in October 2025 and organize a webinar series on bionanoparticle research and applications during Spring 2026.
Contact person
Outi Lampela
Project manager, University of Oulu
outi.lampela@oulu.fi
Source: University of Oulu
